Cargando…

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers

Detalles Bibliográficos
Autores principales:	Mougdil, Tarsem, Paustian, Christopher, Feng, Zipei, Leidner, Rom, Dubay, Christopher, Curti, Brendan D, Hu, Hong-Ming, Urba, Walter, Bifulco, Carlo, Fox, Bernard, Bell, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645346/ http://dx.doi.org/10.1186/2051-1426-3-S2-P37

Ejemplares similares

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
por: Duhen, Rebekka, et al.
Publicado: (2021)

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
por: Feng, Zipei, et al.
Publicado: (2015)

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
por: Andtbacka, Robert HI, et al.
Publicado: (2015)

Assessment of the tumor immune-environment in patients with head and neck cancer
por: Feng, Zipei, et al.
Publicado: (2015)

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer
por: Puri, Sachin, et al.
Publicado: (2014)

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
por: Montler, Ryan, et al.
Publicado: (2016)

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
por: van de Ven, Rieneke, et al.
Publicado: (2018)

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies
por: Fox, Bernard A., et al.
Publicado: (2023)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014)

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
por: Couey, Marcus A., et al.
Publicado: (2019)

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
por: Sanborn, Rachel E., et al.
Publicado: (2017)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
por: Ye, Wei, et al.
Publicado: (2014)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
por: Falchook, Gerald S., et al.
Publicado: (2016)

An image analysis algorithm based on the hue saturation density transformation, an important tool for melanoma immunotherapy research
por: Dzubay, Jeffrey A, et al.
Publicado: (2014)

Rapid expansion of TILs from patients with glioma and recognition of autologous tumor
por: Zhenjiang, Liu, et al.
Publicado: (2014)

Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes
por: Duhen, Thomas, et al.
Publicado: (2022)

Explant Modeling of the Immune Environment of Head and Neck Cancer
por: Sharon, Shay, et al.
Publicado: (2021)

PD-L1 in Combination with CD8(+)TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma
por: Zhou, Zihan, et al.
Publicado: (2020)

Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins
por: Hulett, Tyler, et al.
Publicado: (2014)

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
por: Draghi, Arianna, et al.
Publicado: (2021)

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
por: Duhen, Thomas, et al.
Publicado: (2018)

Fysikkpris til Fanamann
Publicado: (1981)

Petabytes til folket
Publicado: (2005)

Goldilocks and the three TILs
por: Dada, Hannah, et al.
Publicado: (2022)

Radiation and immunotherapy: Renewed allies in the war on cancer
por: Seung, Steven K., et al.
Publicado: (2012)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
por: Arnaud, Marion, et al.
Publicado: (2023)

Back from the dead: TIL apoptosis in cancer immune evasion
por: Horton, Brendan L, et al.
Publicado: (2018)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients
por: Kvistborg, Pia, et al.
Publicado: (2012)

Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder
por: Eismann, Lennert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hcsltpif1kmrod8sgdljbatg04